Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis

Journal of Bone and Mineral Research

Volumn 28, Issue 3, 2013, Pages 559-573

  Yang, Nan ^a,b   Wang, Guang ^a   Hu, Chenghu ^a,c   Shi, Yuanyuan ^d   Liao, Li ^a,c   Shi, Songtao ^e   Cai, Yan ^f   Cheng, Shuli ^a   Wang, Xi ^a   Liu, Yali ^a   Tang, Liang ^a,c   Ding, Yin ^a   Jin, Yan ^a,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c Engineering Technology Center for Tissue Engineering of Xi'an   (China)

^d 306 HOSPITAL OF PLA   (China)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

MESENCHYMAL STEM CELL; miR 21; OSTEOGENESIS; OSTEOPOROSIS; TNF

Indexed keywords

ESTROGEN; MICRORNA 21; PROTEIN; SPRY1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN DEFICIENCY; ESTROGEN DEFICIENCY INDUCED OSTEOPOROSIS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOPOROSIS; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84873944895     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1798     Document Type: Article

References (69)

1. Pacifici R., Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996; 11 (8): 1043-51.
2. Weitzmann MN, Pacifici R., Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006; 116 (5): 1186-94.
3. Clowes JA, Riggs BL, Khosla S., The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005; 208: 207-27.
4. Inada M, Miyaura C., [Cytokines in bone diseases. Cytokine and postmenopausal osteoporosis]. Clin Calcium. 2010; 20 (10): 1467-72. Japanese.
5. Pfeilschifter J, Koditz R, Pfohl M, Schatz H., Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002; 23 (1): 90-119.
6. Delmas PD., The use of bisphosphonates in the treatment of osteoporosis. Curr Opin Rheumatol. 2005; 17 (4): 462-6.
7. Kim H, Choi HK, Shin JH, Kim KH, Huh JY, Lee SA, Ko CY, Kim HS, Shin HI, Lee HJ, Jeong D, Kim N, Choi Y, Lee SY., Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest. 2009; 119 (4): 813-25.
8. Sartori L, Adami S, Filipponi P, Crepaldi G., Injectable bisphosphonates in the treatment of postmenopausal osteoporosis. Aging Clin Exp Res. 2003; 15 (4): 271-83.
9. Khosla S, Westendorf JJ, Oursler MJ., Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008; 118 (2): 421-8.
10. Marie PJ, Kassem M., Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol. 2011; 165 (1): 1-10.
11. Khosla S, Riggs BL., Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am. 2005; 34 (4): 1015-30.
12. Raisz LG., Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115 (12): 3318-25.
13. Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY., Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009; 15 (6): 682-9.
14. Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V., Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009; 60 (11): 3356-65.
15. Zhao L, Huang J, Zhang H, Wang Y, Matesic LE, Takahata M, Awad H, Chen D, Xing L., Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells. 2011; 29 (10): 1601-10.
16. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM., miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 2010; 285 (33): 25221-31.
17. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH., A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest. 2009; 119 (12): 3666-77.
18. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S, Kassem M., MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A. 2011; 108 (15): 6139-44.
19. Hassan MQ, Gordon JA, Beloti MM, Croce CM, Wijnen AJ, Stein JL, Stein GS, Lian JB., A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A. 2010; 107 (46): 19879-84.
20. Huang J, Zhao L, Xing L, Chen D., MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 2010; 28 (2): 357-64.
21. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS., miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res. 2009; 24 (5): 816-25.
22. Yang CH, Yue J, Fan M, Pfeffer LM., IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res. 2010; 70 (20): 8108-16.
23. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB., MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011; 108 (27): 11193-8.
24. Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM., Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011; 108 (12): 4908-13.
25. McCoy CE., The role of miRNAs in cytokine signaling. Front Biosci. 2011; 17: 2161-71.
26. Ma X, Becker Buscaglia LE, Barker JR, Li Y., MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011; 3 (3): 159-66.
27. Liu Y, Liu W, Hu C, Xue Z, Wang G, Ding B, Luo H, Tang L, Kong X, Chen X, Liu N, Ding Y, Jin Y., MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells. 2011; 29 (11): 1804-16.
28. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D., Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl. 2001; 36: 144-55.
29. Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ, Pochampally R., Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A. 2008; 105 (47): 18372-7.
30. Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, Saito K, Nakamura T, Siomi H, Ito H, Arai Y, Shinomiya K, Takeda S., A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A. 2009; 106 (49): 20794-9.
31. Wu JY, Aarnisalo P, Bastepe M, Sinha P, Fulzele K, Selig MK, Chen M, Poulton IJ, Purton LE, Sims NA, Weinstein LS, Kronenberg HM., Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest. 2011; 121 (9): 3492-504.
32. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E., Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest. 2003; 112 (6): 924-34.
33. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS., A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A. 2008; 105 (37): 13906-11.
34. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T., A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005; 65 (21): 9628-32.
35. Hossain A, Kuo MT, Saunders GF., Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006; 26 (21): 8191-201.
36. Krichevsky AM, Gabriely G., miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009; 13 (1): 39-53.
37. Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M., MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell. 2008; 19 (8): 3272-82.
38. Kim YJ, Hwang SJ, Bae YC, Jung JS., MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 2009; 27 (12): 3093-102.
39. Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C, Lobo DN, Larvin M., Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2011; 15 (1): 199-208.
40. Gangaraju VK, Lin H., MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol. 2009; 10 (2): 116-25.
41. Houbaviy HB, Murray MF, Sharp PA., Embryonic stem cell-specific microRNAs. Dev Cell. 2003; 5 (2): 351-8.
42. Kim YJ, Hwang SH, Cho HH, Shin KK, Bae YC, Jung JS., MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol. 2012; 227 (1): 183-93.
43. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V., PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008; 112 (2): 295-307.
44. Huang Z, Ren PG, Ma T, Smith RL, Goodman SB., Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine. 2010; 51 (3): 305-10.
45. Lei SF, Papasian CJ, Deng HW., Polymorphisms in predicted miRNA binding sites and osteoporosis. J Bone Miner Res. 2011; 26 (1): 72-8.
46. Ge C, Xiao G, Jiang D, Franceschi RT., Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol. 2007; 176 (5): 709-18.
47. Park OJ, Kim HJ, Woo KM, Baek JH, Ryoo HM., FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J Biol Chem. 2010; 285 (6): 3568-74.
48. Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT., Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem. 2009; 284 (47): 32533-43.
49. Komori T., Signaling networks in RUNX2-dependent bone development. J Cell Biochem. 2011; 112 (3): 750-5.
50. Kwabi-Addo B, Ren C, Ittmann M., DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics. 2009; 4 (1): 54-61.
51. Zhang B, Li Y, Zhou Q, Ding Y., Estrogen deficiency leads to impaired osteogenic differentiation of periodontal ligament stem cells in rats. Tohoku J Exp Med. 2011; 223 (3): 177-86.
52. Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM., Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007; 16 (2): 121-8.
53. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S., Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009; 27 (6): 1421-32.
54. Nanes MS., Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003; 321: 1-15.
55. Roggia C, Tamone C, Cenci S, Pacifici R, Isaia GC., Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med. 2004; 95 (2): 125-32.
56. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R., Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. 2001; 98 (24): 13960-5.
57. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL., Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res. 2007; 22 (5): 724-9.
58. Kimble RB, Bain S, Pacifici R., The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res. 1997; 12 (6): 935-41.
59. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R., Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000; 106 (10): 1229-37.
60. Rincon M, Rudin E, Barzilai N., The insulin/IGF-1 signaling in mammals and its relevance to human longevity. Exp Gerontol. 2005; 40 (11): 873-7.
61. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ., Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res. 2008; 18 (6): 455-71.
62. Salminen A, Kaarniranta K., Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell Signal. 2010; 22 (4): 573-7.
63. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS., Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 2000; 141 (11): 3956-64.
64. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS., Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2002; 277 (4): 2695-701.
65. Wahl EC, Aronson J, Liu L, Fowlkes JL, Thrailkill KM, Bunn RC, Skinner RA, Miller MJ, Cockrell GE, Clark LM, Ou Y, Isales CM, Badger TM, Ronis MJ, Sims J., Lumpkin CK Jr. Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res. 2010; 25 (1): 114-23.
66. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H., Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 2009; 37 (14): 4850-61.
67. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM., Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 2009; 37 (8): 2584-95.
68. Klinge CM., Estrogen regulation of microRNA expression. Curr Genomics. 2009; 10 (3): 169-83.
69. Matsumoto Y, Otsuka F, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H., Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol. 2010; 325 (1-2): 118-27.